Sunday, September 26, 2021
Home News Medical News

Medical News

A new study has found that adults with neurological conditions are more likely to have experienced adverse traumatic events in childhood. However, the study does not prove that adverse childhood experiences cause neurological conditions in adults. Instead, it just shows a link between the two.
A team of researchers at the University of Illinois Urbana-Champaign has developed a sensor using DNA fragments and sensing technology to target and detect infectious viruses in minutes. The sensor can also detect how much contagious the virus is. The team studied the sensor on the human adenovirus and the coronavirus.
Rush University Medical Center researchers have developed potential new nasal drugs that could help slow the progression of Parkinson’s disease. The researchers, who published their findings in Nature Communications, have shown that these drugs could also reduce inflammation of the brain.
Texas introduced anti-abortion law that came into effect on September 1, 2021. However, a Texan physician, Dr. Alan Braid, said that he performed an abortion on September 6, calling it a “duty of care.” Dr. Brain could be sued for breaking the new law, but got support from an abortion-rights advocacy group.
The Food and Drug Administration (FDA) has accepted Intellia Pharmaceuticals’ Investigational New Drug (IND) application for its experimental drug NTLA-5001 for the treatment of acute myeloid leukemia (AML). AML is a cancer of the blood and bone marrow, according to National Cancer Institute.
The Food and Drug Administration (FDA) has granted key drug approvals for the treatment of rare and serious medical conditions. For instance, the FDA issues Fast Track designation to SAGE-178, an experimental drug for Huntington disease, opelconazole for invasive pulmonary aspergillosis, among others.
An article published in Forbes explained that Democrat’s plans to introduce prescription drug pricing reform face formidable challenges, which will dim prospects of a meaningful change. In July, President Joe Biden asked HHS to submit a report on how to reduce high prescription drug prices.